Anti-EBV Latent Membrane Protein 1 antibody [CS1, CS2, CS3, CS4], prediluted (ab7502)


  • Product name
    Anti-EBV Latent Membrane Protein 1 antibody [CS1, CS2, CS3, CS4], prediluted
    See all EBV Latent Membrane Protein 1 primary antibodies
  • Description
    Mouse monoclonal [CS1, CS2, CS3, CS4] to EBV Latent Membrane Protein 1, prediluted
  • Host species
  • Specificity
    This antibody is specific to 60 kD latent membrane protein (LMP1) encoded by the BNLF1 gene of the EBV. Each clone reacts with different epitopes on the hydrophilic c-terminus of the cytoplasmic domain of LMP1. This antibody stains strongly with EBV positive lymphoblastoid cell lines and EBV infected B cell immunoblasts in infectious mononucleosis.
  • Tested applications
    Suitable for: IHC-P, IHC-Frmore details
  • Species reactivity
  • Immunogen

    Recombinant fusion protein containing sequences of bacterial beta-galactosidase and EBV encoded Latent membrane protein.

  • Positive control
    • Infected lymphoblastoma.



Our Abpromise guarantee covers the use of ab7502 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P Use at an assay dependent concentration. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
IHC-Fr Use at an assay dependent concentration.


  • Relevance
    EBV is a human herpesvirus that establishes a life-long persistence in the host. The virus infects the vast majority of the world's adult population and is well known for its association with a broad spectrum of benign and malignant diseases, including infectious mononucleosis, Burkitt's lymphoma, nasopharyngeal carcinoma, and is causally associated with lymphoid and epithelial malignancies, including post-transplant lymphoproliferative disorders, Hodgkin's disease, anaplastic nasopharyngeal carcinoma and gastric carcinomas. Latent membrane protein 1 (LMP1) of Epstein-Barr virus (EBV) is a transforming protein that affects multiple cell signalling pathways and contributes to EBV-associated oncogenesis. LMP1 can be expressed in some states of EBV latency, and significant induction of full-length LMP1 is also observed frequently during virus reactivation into the lytic cycle. LMP1 is critical for EBV-infected cell activation, adhesion and survival, and is usually expressed in the malignant cells.
  • Alternative names
    • BNLF1 antibody
    • EBV antibody
    • Epstein Barr virus antibody
    • HHV4 antibody
    • Human Herpesvirus 4 antibody
    • Latent membrane protein 1 antibody
    • LMP1 antibody
    see all


  • The image shows lung tissue diagnosed with Post-Transplantation Lymphoproliferative Disorder (PTLD). Mononuclear cells are stained brown with DAB chromogen around the cytoplasm - typical for Latent Membrane Protein-1 of EBV.

    This picture was kindly supplied as part of the review submitted by Pradeep Rai.


This product has been referenced in:
  • Nawandar DM  et al. Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells. J Virol 91:N/A (2017). Read more (PubMed: 28179525) »

See 1 Publication for this product

Customer reviews and Q&As

Thank you for taking time to contact us. I am sorry to hear that this antibody is not providing satisfactory results. The details provided will enable us to investigate this case and will provide us with vital information for monitoring product quality...

Read More

Thank you for contacting us. This antibody is non-hazardous. Please find the requested MSDS for non-hazardous products attached. Let me know if you need any additional information or assistance.

Thank you for your enquiry. Unfortunately this information was not released by the originator of the antibody. I am sorry I could not be more helpful. Please do not hesitate to contact us if you need anything further.

The approximate concentration of ab7502 is 8 ug/ml.


Sign up